Nxera Pharma Co., Ltd.
Nxera Pharma Co., Ltd. 4565.T Peers
See (4565.T) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 4565.T | $834.00 | -2.11% | 74.98B | -32.48 | -$25.68 | N/A |
| 4587.T | $1,712.00 | -7.48% | 221.12B | 14.80 | $115.66 | N/A |
| 4592.T | $2,670.00 | -1.15% | 192.28B | -63.66 | -$41.94 | N/A |
| 2160.T | $2,476.00 | -0.40% | 124.33B | 117.40 | $21.09 | N/A |
| 4974.T | $783.00 | -3.21% | 94.29B | -1957.50 | -$0.40 | +2.17% |
| 4894.T | $6,890.00 | -0.72% | 55.76B | -71.42 | -$96.47 | N/A |
| 4593.T | $320.00 | -0.31% | 32.47B | -6.69 | -$47.86 | N/A |
| 7774.T | $591.00 | -2.31% | 24.00B | -358.18 | -$1.65 | N/A |
| 4563.T | $62.00 | -3.13% | 21.95B | -0.52 | -$119.53 | N/A |
| 4575.T | $1,054.00 | +6.04% | 20.13B | -14.79 | -$71.27 | N/A |
Stock Comparison
4565.T vs 4587.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4587.T has a market cap of 221.12B. Regarding current trading prices, 4565.T is priced at $834.00, while 4587.T trades at $1,712.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4587.T's P/E ratio is 14.80. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4587.T's ROE of +0.28%. Regarding short-term risk, 4565.T is less volatile compared to 4587.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4592.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4592.T has a market cap of 192.28B. Regarding current trading prices, 4565.T is priced at $834.00, while 4592.T trades at $2,670.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4592.T's P/E ratio is -63.66. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4592.T's ROE of -1.82%. Regarding short-term risk, 4565.T is less volatile compared to 4592.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 2160.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 2160.T has a market cap of 124.33B. Regarding current trading prices, 4565.T is priced at $834.00, while 2160.T trades at $2,476.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 2160.T's P/E ratio is 117.40. In terms of profitability, 4565.T's ROE is -0.07%, compared to 2160.T's ROE of +0.03%. Regarding short-term risk, 4565.T is more volatile compared to 2160.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4974.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4974.T has a market cap of 94.29B. Regarding current trading prices, 4565.T is priced at $834.00, while 4974.T trades at $783.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4974.T's P/E ratio is -1957.50. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4974.T's ROE of -0.00%. Regarding short-term risk, 4565.T is less volatile compared to 4974.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4894.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4894.T has a market cap of 55.76B. Regarding current trading prices, 4565.T is priced at $834.00, while 4894.T trades at $6,890.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4894.T's P/E ratio is -71.42. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4894.T's ROE of -0.13%. Regarding short-term risk, 4565.T is more volatile compared to 4894.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4593.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4593.T has a market cap of 32.47B. Regarding current trading prices, 4565.T is priced at $834.00, while 4593.T trades at $320.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4593.T's P/E ratio is -6.69. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4593.T's ROE of -1.58%. Regarding short-term risk, 4565.T is less volatile compared to 4593.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 7774.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 7774.T has a market cap of 24.00B. Regarding current trading prices, 4565.T is priced at $834.00, while 7774.T trades at $591.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 7774.T's P/E ratio is -358.18. In terms of profitability, 4565.T's ROE is -0.07%, compared to 7774.T's ROE of -0.03%. Regarding short-term risk, 4565.T is less volatile compared to 7774.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4563.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4563.T has a market cap of 21.95B. Regarding current trading prices, 4565.T is priced at $834.00, while 4563.T trades at $62.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4563.T's P/E ratio is -0.52. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4563.T's ROE of -1.50%. Regarding short-term risk, 4565.T is less volatile compared to 4563.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4575.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4575.T has a market cap of 20.13B. Regarding current trading prices, 4565.T is priced at $834.00, while 4575.T trades at $1,054.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4575.T's P/E ratio is -14.79. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4575.T's ROE of -0.28%. Regarding short-term risk, 4565.T is less volatile compared to 4575.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4599.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4599.T has a market cap of 18.33B. Regarding current trading prices, 4565.T is priced at $834.00, while 4599.T trades at $295.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4599.T's P/E ratio is -8.80. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4599.T's ROE of -0.24%. Regarding short-term risk, 4565.T is less volatile compared to 4599.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 7776.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 7776.T has a market cap of 17.65B. Regarding current trading prices, 4565.T is priced at $834.00, while 7776.T trades at $509.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 7776.T's P/E ratio is -19.80. In terms of profitability, 4565.T's ROE is -0.07%, compared to 7776.T's ROE of -0.40%. Regarding short-term risk, 4565.T is less volatile compared to 7776.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4978.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4978.T has a market cap of 15.25B. Regarding current trading prices, 4565.T is priced at $834.00, while 4978.T trades at $161.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4978.T's P/E ratio is -124.81. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4978.T's ROE of -0.01%. Regarding short-term risk, 4565.T is less volatile compared to 4978.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4889.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4889.T has a market cap of 15.00B. Regarding current trading prices, 4565.T is priced at $834.00, while 4889.T trades at $1,180.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4889.T's P/E ratio is -63.58. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4889.T's ROE of +0.07%. Regarding short-term risk, 4565.T is less volatile compared to 4889.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4588.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4588.T has a market cap of 13.29B. Regarding current trading prices, 4565.T is priced at $834.00, while 4588.T trades at $535.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4588.T's P/E ratio is -6.93. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4588.T's ROE of -0.86%. Regarding short-term risk, 4565.T is less volatile compared to 4588.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4880.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4880.T has a market cap of 12.90B. Regarding current trading prices, 4565.T is priced at $834.00, while 4880.T trades at $651.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4880.T's P/E ratio is 54.39. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4880.T's ROE of +0.01%. Regarding short-term risk, 4565.T is less volatile compared to 4880.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 7096.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 7096.T has a market cap of 12.57B. Regarding current trading prices, 4565.T is priced at $834.00, while 7096.T trades at $1,236.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 7096.T's P/E ratio is 29.93. In terms of profitability, 4565.T's ROE is -0.07%, compared to 7096.T's ROE of +0.14%. Regarding short-term risk, 4565.T is less volatile compared to 7096.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4888.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4888.T has a market cap of 10.75B. Regarding current trading prices, 4565.T is priced at $834.00, while 4888.T trades at $316.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4888.T's P/E ratio is -13.79. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4888.T's ROE of -0.24%. Regarding short-term risk, 4565.T is less volatile compared to 4888.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4579.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4579.T has a market cap of 10.53B. Regarding current trading prices, 4565.T is priced at $834.00, while 4579.T trades at $431.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4579.T's P/E ratio is -18.86. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4579.T's ROE of -0.09%. Regarding short-term risk, 4565.T is less volatile compared to 4579.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4875.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4875.T has a market cap of 10.10B. Regarding current trading prices, 4565.T is priced at $834.00, while 4875.T trades at $206.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4875.T's P/E ratio is -6.14. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4875.T's ROE of -7.57%. Regarding short-term risk, 4565.T is less volatile compared to 4875.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4583.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4583.T has a market cap of 9.53B. Regarding current trading prices, 4565.T is priced at $834.00, while 4583.T trades at $140.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4583.T's P/E ratio is -7.98. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4583.T's ROE of -0.75%. Regarding short-term risk, 4565.T is less volatile compared to 4583.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 177A.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 177A.T has a market cap of 9.44B. Regarding current trading prices, 4565.T is priced at $834.00, while 177A.T trades at $1,846.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 177A.T's P/E ratio is 19.96. In terms of profitability, 4565.T's ROE is -0.07%, compared to 177A.T's ROE of +0.14%. Regarding short-term risk, 4565.T is less volatile compared to 177A.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4571.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4571.T has a market cap of 9.39B. Regarding current trading prices, 4565.T is priced at $834.00, while 4571.T trades at $133.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4571.T's P/E ratio is -14.70. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4571.T's ROE of -0.20%. Regarding short-term risk, 4565.T is more volatile compared to 4571.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 206A.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 206A.T has a market cap of 8.95B. Regarding current trading prices, 4565.T is priced at $834.00, while 206A.T trades at $244.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 206A.T's P/E ratio is -7.27. In terms of profitability, 4565.T's ROE is -0.07%, compared to 206A.T's ROE of -0.32%. Regarding short-term risk, 4565.T is less volatile compared to 206A.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4896.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4896.T has a market cap of 8.61B. Regarding current trading prices, 4565.T is priced at $834.00, while 4896.T trades at $742.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4896.T's P/E ratio is -10.17. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4896.T's ROE of -0.33%. Regarding short-term risk, 4565.T is more volatile compared to 4896.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 2370.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 2370.T has a market cap of 8.21B. Regarding current trading prices, 4565.T is priced at $834.00, while 2370.T trades at $31.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 2370.T's P/E ratio is -6.15. In terms of profitability, 4565.T's ROE is -0.07%, compared to 2370.T's ROE of -0.26%. Regarding short-term risk, 4565.T is less volatile compared to 2370.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 2183.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 2183.T has a market cap of 6.75B. Regarding current trading prices, 4565.T is priced at $834.00, while 2183.T trades at $299.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 2183.T's P/E ratio is -55.68. In terms of profitability, 4565.T's ROE is -0.07%, compared to 2183.T's ROE of -0.03%. Regarding short-term risk, 4565.T is more volatile compared to 2183.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4893.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4893.T has a market cap of 6.58B. Regarding current trading prices, 4565.T is priced at $834.00, while 4893.T trades at $152.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4893.T's P/E ratio is -6.82. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4893.T's ROE of -0.19%. Regarding short-term risk, 4565.T is less volatile compared to 4893.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4564.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4564.T has a market cap of 6.34B. Regarding current trading prices, 4565.T is priced at $834.00, while 4564.T trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4564.T's P/E ratio is -4.78. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4564.T's ROE of -1.40%. Regarding short-term risk, 4565.T is less volatile compared to 4564.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4584.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4584.T has a market cap of 6.33B. Regarding current trading prices, 4565.T is priced at $834.00, while 4584.T trades at $133.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4584.T's P/E ratio is -5.99. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4584.T's ROE of -1.00%. Regarding short-term risk, 4565.T is less volatile compared to 4584.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 3750.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 3750.T has a market cap of 6.18B. Regarding current trading prices, 4565.T is priced at $834.00, while 3750.T trades at $692.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 3750.T's P/E ratio is 41.51. In terms of profitability, 4565.T's ROE is -0.07%, compared to 3750.T's ROE of -0.02%. Regarding short-term risk, 4565.T is less volatile compared to 3750.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4891.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4891.T has a market cap of 5.92B. Regarding current trading prices, 4565.T is priced at $834.00, while 4891.T trades at $136.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4891.T's P/E ratio is -4.77. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4891.T's ROE of -0.22%. Regarding short-term risk, 4565.T is less volatile compared to 4891.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4884.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4884.T has a market cap of 5.58B. Regarding current trading prices, 4565.T is priced at $834.00, while 4884.T trades at $816.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4884.T's P/E ratio is -6.90. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4884.T's ROE of -0.37%. Regarding short-term risk, 4565.T is less volatile compared to 4884.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4572.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4572.T has a market cap of 5.06B. Regarding current trading prices, 4565.T is priced at $834.00, while 4572.T trades at $265.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4572.T's P/E ratio is -2.18. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4572.T's ROE of -0.73%. Regarding short-term risk, 4565.T is less volatile compared to 4572.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4598.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4598.T has a market cap of 4.72B. Regarding current trading prices, 4565.T is priced at $834.00, while 4598.T trades at $469.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4598.T's P/E ratio is -2.15. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4598.T's ROE of -2.38%. Regarding short-term risk, 4565.T is more volatile compared to 4598.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4576.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4576.T has a market cap of 4.61B. Regarding current trading prices, 4565.T is priced at $834.00, while 4576.T trades at $106.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4576.T's P/E ratio is -2.89. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4576.T's ROE of -1.45%. Regarding short-term risk, 4565.T is less volatile compared to 4576.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4570.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4570.T has a market cap of 4.30B. Regarding current trading prices, 4565.T is priced at $834.00, while 4570.T trades at $462.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4570.T's P/E ratio is 18.58. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4570.T's ROE of +0.23%. Regarding short-term risk, 4565.T is less volatile compared to 4570.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 2385.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 2385.T has a market cap of 4.11B. Regarding current trading prices, 4565.T is priced at $834.00, while 2385.T trades at $157.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 2385.T's P/E ratio is -10.36. In terms of profitability, 4565.T's ROE is -0.07%, compared to 2385.T's ROE of -0.06%. Regarding short-term risk, 4565.T is less volatile compared to 2385.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4594.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4594.T has a market cap of 3.88B. Regarding current trading prices, 4565.T is priced at $834.00, while 4594.T trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4594.T's P/E ratio is -2.54. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4594.T's ROE of -1.03%. Regarding short-term risk, 4565.T is less volatile compared to 4594.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4881.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4881.T has a market cap of 3.82B. Regarding current trading prices, 4565.T is priced at $834.00, while 4881.T trades at $103.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4881.T's P/E ratio is -3.22. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4881.T's ROE of -0.36%. Regarding short-term risk, 4565.T is less volatile compared to 4881.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4591.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4591.T has a market cap of 3.75B. Regarding current trading prices, 4565.T is priced at $834.00, while 4591.T trades at $84.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4591.T's P/E ratio is -3.27. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4591.T's ROE of -0.30%. Regarding short-term risk, 4565.T is less volatile compared to 4591.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 2342.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 2342.T has a market cap of 2.63B. Regarding current trading prices, 4565.T is priced at $834.00, while 2342.T trades at $158.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 2342.T's P/E ratio is -11.63. In terms of profitability, 4565.T's ROE is -0.07%, compared to 2342.T's ROE of -0.04%. Regarding short-term risk, 4565.T is more volatile compared to 2342.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 4596.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 4596.T has a market cap of 2.59B. Regarding current trading prices, 4565.T is priced at $834.00, while 4596.T trades at $44.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 4596.T's P/E ratio is -1.86. In terms of profitability, 4565.T's ROE is -0.07%, compared to 4596.T's ROE of -0.72%. Regarding short-term risk, 4565.T is less volatile compared to 4596.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.
4565.T vs 6190.T Comparison
4565.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4565.T stands at 74.98B. In comparison, 6190.T has a market cap of 1.44B. Regarding current trading prices, 4565.T is priced at $834.00, while 6190.T trades at $355.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4565.T currently has a P/E ratio of -32.48, whereas 6190.T's P/E ratio is -11.37. In terms of profitability, 4565.T's ROE is -0.07%, compared to 6190.T's ROE of -0.08%. Regarding short-term risk, 4565.T is less volatile compared to 6190.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4565.T.